To determine the functional relationship between CREB5 and MET in the invasion and metastasis of CRC, we knocked down MET using two MET shRNAs or suppressed MET activation using the MET inhibitor crizotinib (EMD 1214063). This evidence concerns the gene CREB5 and colorectal carcinoma.